1. Executive Summary 2. United States Diabetes Population & Forecast (2013 – 2026) 3. United States Insulin Users & Forecast (2013 – 2026) 4. United States Insulin Delivery Pen Users & Market Analysis (2013 – 2026) 4.1 Insulin Delivery Pen Users & Forecast 4.2 Insulin Delivery Pen Market & Forecast 5. United States Insulin Delivery Pen Users, Market Share& Y–o–Y Growth (%), 2013 – 2026 5.1 Insulin Delivery Pen Users Share & Forecast 5.2 Insulin Delivery Pen Market Share & Forecast 6. United States Insulin Delivery Pen Devices Users & Market Forecast (2013 – 2026) 6.1 Reusable (Cartridge) Insulin Delivery Pen Users & Market 6.1.1 Reusable (Cartridge) Insulin Delivery Pen Users 6.1.2 Reusable (Cartridge) Insulin Delivery Pen Market 6.2 Prefilled (Disposable) Insulin Delivery Pen Users & Market 6.2.1 Prefilled (Disposable) Insulin Delivery Pen Users 6.2.2 Prefilled (Disposable) Insulin Delivery Pen Market 6.3 Smart Insulin Delivery Pen Users & Market 6.3.1 Smart Insulin Delivery Pen Users 6.3.2 Smart Insulin Delivery Pen Market 7. Key Drivers and Inhibitors of the United States Insulin Delivery Pen Market 7.1 Market Drivers 7.2 Market Inhibitors 8. United States Insulin Delivery Pen Reimbursement Policies & Regulation System 8.1 Reimbursement Policies 8.2 Regulation System 9. Key Companies Analysis 9.1 Novo Nordisk 9.1.1 Business Overview 9.1.2 Insulin Delivery Pen Products Offered 9.1.3 Recent Development 9.2 Eli Lilly 9.2.1 Business Overview 9.2.2 Insulin Delivery Pen Products Offered 9.2.3 Recent Development 9.3 Sanofi 9.3.1 Business Overview 9.3.2 Insulin Delivery Pen Products Offered 9.3.3 Recent Development 9.4 Owen Mumford 9.4.1 Business Overview 9.4.2 Insulin Delivery Pen Products Offered 9.4.3 Recent Development 9.5 Companion Medical 9.5.1 Business Overview 9.5.2 Insulin Delivery Pen Products Offered 9.5.3 Recent Development 9.6 Diabnext 9.6.1 Business Overview 9.6.2 Insulin Delivery Pen Products Offered 9.6.3 Recent Development 9.7 Digital Medics Ptd Ltd. 9.7.1 Business Overview 9.7.2 Insulin Delivery Pen Products Offered 9.7.3 Recent Development 9.8 Emperra GmbH E-Health Technologies 9.8.1 Business Overview 9.8.2 Insulin Delivery Pen Products Offered 9.8.3 Recent Development 9.9 Diamesco Co., Ltd. 9.9.1 Business Overview 9.9.2 Insulin Delivery Pen Products Offered 9.9.3 Recent Development

Table 5–1: United States Insulin Delivery Pen Users Share (Percent),2013 – 2018 Table 5–2: United States Insulin Delivery Pen Users Share Forecast (Percent),2019 – 2026 Table 5–3: United States Insulin Delivery Pen Market Share (Percent),2013 – 2018 Table 5–4: United States Insulin Delivery Pen Market Share Forecast (Percent),2019 – 2026 Table 7–1: Worldwide Healthcare Spending on Diabetes (Billion US$), 2015 & 2040Figure 2–1: United States Diabetes Population (Thousand), 2013 – 2018 Figure 2–2: United States Diabetes Population Forecast (Thousand), 2019 – 2026 Figure 3–1: United States Insulin Users (Thousand),2013 – 2018 Figure 3–2: United States Insulin Users Forecast (Thousand),2019 – 2026 Figure 4–1: United States Insulin Delivery Pen Users (Thousand), 2013 – 2018 Figure 4–2: United States Insulin Delivery Pen Users Forecast (Thousand), 2019 – 2026 Figure 4–3: United States Insulin Delivery Pen Market (Million US$), 2013 – 2018 Figure 4–4: United States Insulin Delivery Pen Market Forecast (Million US$), 2019 – 2026 Figure 6–1: United States Reusable Insulin Delivery Pen Users (Thousand), 2013 – 2018 Figure 6–2: United States Reusable Insulin Delivery Pen Users Forecast (Thousand), 2019 – 2026 Figure 6–3: United States Reusable Insulin Delivery Pen Market (Million US$), 2013 – 2018 Figure 6–4: United States Reusable Insulin Delivery Pen Market Forecast (Million US$), 2019 – 2026 Figure 6–5: United States Prefilled Insulin Delivery Pen Users (Thousand), 2013 – 2018 Figure 6–6: United States Prefilled Insulin Delivery Pen Users Forecast (Thousand), 2019 – 2026 Figure 6–7: United States Prefilled Insulin Delivery Pen Market (Million US$), 2013 – 2018 Figure 6–8: United States Prefilled Insulin Delivery Pen Market Forecast (Million US$), 2019 – 2026 Figure 6–9: United States Smart Insulin Delivery Pen Users & Forecast (Thousand), 2018 – 2026 Figure 6–10: United States Smart Insulin Delivery Pen Market & Forecast (Million US$), 2018 – 2026

Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Companion Medical, Diabnext, Digital Medics Ptd Ltd., Emperra GmbH E-Health Technologies and Diamesco Co., Ltd.